Global New Generation Implants

New Generation Implants Comprehensive Study by Type (Endosteal,, Subperiosteal,, Zygomatic.), Application (Orthopedic Implants, Cardiovascular Implants, Ocular Implants, Dental Implants), Raw Material (Metals and Alloys, Ceramics, Polymers, Biologicals, Others) Players and Region - Global Market Outlook to 2030

New Generation Implants Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global New Generation Implants Market Overview:
Medical implants are devices that are inserted or grafted into the body of a patient to serve as a part or entire organ. An implant, according to the US Food and Drug Administration, is a device or tissue that can be placed on the surface or inside the body. These devices help to support existing organs, replace them, or replace missing portions. These types of implants are also being used by the younger generation as a result of lifestyle changes. Increased physical inactivity, obesity, and fast food intake are all factors that contribute to the development of such diseases and, as a result, boost the demand for implant devices.

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Increase in research and development for the discovery of new products

Market Growth Drivers:
Growing cases of chronic diseases and the increasing geriatric population and Increasing geriatric population suffering from bone fractures

Challenges:
The exceptionally high corrosion rate in the physiological environment

Restraints:
High cost of implants and surgery

Opportunities:
Rising demand for new generation implants in developing countries and Advanced product development

Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Abbott Laboratories (United States), Arthrex (United States), Biotronik SE & Co. KG (Germany), Boston Scientific Corporation (United States), C. R. BARD, INC. (United States), Danaher Corporation (United States), Dentsply Sirona (United States), Edwards Lifesciences Corporation (United States), Globus Medical Inc. (United States) and Integer Holdings Corporation (United States). Additionally, following companies can also be profiled that are part of our coverage like Integra LifeSciences Corporation (United States), Institut Straumann AG (Switzerland) and LifeNet Health, Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global New Generation Implants market by 2030. Considering Market by Raw Material, the sub-segment i.e. Metals and Alloys will boost the New Generation Implants market.

Latest Market Insights:


In June , 2022 ZimVie Inc. a global life sciences leader in the dental and spine markets, today announced the joint launch of the new, FDA-cleared T3® PRO Tapered Implant and Encode® Emergence Healing Abutment in the United States. The T3 PRO is the newest addition to ZimVie’s family of dental implants and builds on the proven solutions of the T3 Tapered Implant.

What Can be Explored with the New Generation Implants Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global New Generation Implants Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in New Generation Implants
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global New Generation Implants market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in New Generation Implants market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants and Investors, New Generation Implants Provider, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • endosteal,
  • subperiosteal,
  • zygomatic.
By Application
  • Orthopedic Implants
  • Cardiovascular Implants
  • Ocular Implants
  • Dental Implants
By Raw Material
  • Metals and Alloys
  • Ceramics
  • Polymers
  • Biologicals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing cases of chronic diseases and the increasing geriatric population
      • 3.2.2. Increasing geriatric population suffering from bone fractures
    • 3.3. Market Challenges
      • 3.3.1. The exceptionally high corrosion rate in the physiological environment
    • 3.4. Market Trends
      • 3.4.1. Increase in research and development for the discovery of new products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global New Generation Implants, by Type, Application, Raw Material and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global New Generation Implants (Value)
      • 5.2.1. Global New Generation Implants by: Type (Value)
        • 5.2.1.1. Endosteal,
        • 5.2.1.2. Subperiosteal,
        • 5.2.1.3. Zygomatic.
      • 5.2.2. Global New Generation Implants by: Application (Value)
        • 5.2.2.1. Orthopedic Implants
        • 5.2.2.2. Cardiovascular Implants
        • 5.2.2.3. Ocular Implants
        • 5.2.2.4. Dental Implants
      • 5.2.3. Global New Generation Implants by: Raw Material (Value)
        • 5.2.3.1. Metals and Alloys
        • 5.2.3.2. Ceramics
        • 5.2.3.3. Polymers
        • 5.2.3.4. Biologicals
        • 5.2.3.5. Others
      • 5.2.4. Global New Generation Implants Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. New Generation Implants: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Arthrex (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biotronik SE & Co. KG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. C. R. BARD, INC. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Danaher Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Dentsply Sirona (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Edwards Lifesciences Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Globus Medical Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Integer Holdings Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global New Generation Implants Sale, by Type, Application, Raw Material and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global New Generation Implants (Value)
      • 7.2.1. Global New Generation Implants by: Type (Value)
        • 7.2.1.1. Endosteal,
        • 7.2.1.2. Subperiosteal,
        • 7.2.1.3. Zygomatic.
      • 7.2.2. Global New Generation Implants by: Application (Value)
        • 7.2.2.1. Orthopedic Implants
        • 7.2.2.2. Cardiovascular Implants
        • 7.2.2.3. Ocular Implants
        • 7.2.2.4. Dental Implants
      • 7.2.3. Global New Generation Implants by: Raw Material (Value)
        • 7.2.3.1. Metals and Alloys
        • 7.2.3.2. Ceramics
        • 7.2.3.3. Polymers
        • 7.2.3.4. Biologicals
        • 7.2.3.5. Others
      • 7.2.4. Global New Generation Implants Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. New Generation Implants: by Type(USD Million)
  • Table 2. New Generation Implants Endosteal, , by Region USD Million (2018-2023)
  • Table 3. New Generation Implants Subperiosteal, , by Region USD Million (2018-2023)
  • Table 4. New Generation Implants Zygomatic. , by Region USD Million (2018-2023)
  • Table 5. New Generation Implants: by Application(USD Million)
  • Table 6. New Generation Implants Orthopedic Implants , by Region USD Million (2018-2023)
  • Table 7. New Generation Implants Cardiovascular Implants , by Region USD Million (2018-2023)
  • Table 8. New Generation Implants Ocular Implants , by Region USD Million (2018-2023)
  • Table 9. New Generation Implants Dental Implants , by Region USD Million (2018-2023)
  • Table 10. New Generation Implants: by Raw Material(USD Million)
  • Table 11. New Generation Implants Metals and Alloys , by Region USD Million (2018-2023)
  • Table 12. New Generation Implants Ceramics , by Region USD Million (2018-2023)
  • Table 13. New Generation Implants Polymers , by Region USD Million (2018-2023)
  • Table 14. New Generation Implants Biologicals , by Region USD Million (2018-2023)
  • Table 15. New Generation Implants Others , by Region USD Million (2018-2023)
  • Table 16. South America New Generation Implants, by Country USD Million (2018-2023)
  • Table 17. South America New Generation Implants, by Type USD Million (2018-2023)
  • Table 18. South America New Generation Implants, by Application USD Million (2018-2023)
  • Table 19. South America New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 20. Brazil New Generation Implants, by Type USD Million (2018-2023)
  • Table 21. Brazil New Generation Implants, by Application USD Million (2018-2023)
  • Table 22. Brazil New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 23. Argentina New Generation Implants, by Type USD Million (2018-2023)
  • Table 24. Argentina New Generation Implants, by Application USD Million (2018-2023)
  • Table 25. Argentina New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 26. Rest of South America New Generation Implants, by Type USD Million (2018-2023)
  • Table 27. Rest of South America New Generation Implants, by Application USD Million (2018-2023)
  • Table 28. Rest of South America New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 29. Asia Pacific New Generation Implants, by Country USD Million (2018-2023)
  • Table 30. Asia Pacific New Generation Implants, by Type USD Million (2018-2023)
  • Table 31. Asia Pacific New Generation Implants, by Application USD Million (2018-2023)
  • Table 32. Asia Pacific New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 33. China New Generation Implants, by Type USD Million (2018-2023)
  • Table 34. China New Generation Implants, by Application USD Million (2018-2023)
  • Table 35. China New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 36. Japan New Generation Implants, by Type USD Million (2018-2023)
  • Table 37. Japan New Generation Implants, by Application USD Million (2018-2023)
  • Table 38. Japan New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 39. India New Generation Implants, by Type USD Million (2018-2023)
  • Table 40. India New Generation Implants, by Application USD Million (2018-2023)
  • Table 41. India New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 42. South Korea New Generation Implants, by Type USD Million (2018-2023)
  • Table 43. South Korea New Generation Implants, by Application USD Million (2018-2023)
  • Table 44. South Korea New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 45. Taiwan New Generation Implants, by Type USD Million (2018-2023)
  • Table 46. Taiwan New Generation Implants, by Application USD Million (2018-2023)
  • Table 47. Taiwan New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 48. Australia New Generation Implants, by Type USD Million (2018-2023)
  • Table 49. Australia New Generation Implants, by Application USD Million (2018-2023)
  • Table 50. Australia New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific New Generation Implants, by Type USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific New Generation Implants, by Application USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 54. Europe New Generation Implants, by Country USD Million (2018-2023)
  • Table 55. Europe New Generation Implants, by Type USD Million (2018-2023)
  • Table 56. Europe New Generation Implants, by Application USD Million (2018-2023)
  • Table 57. Europe New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 58. Germany New Generation Implants, by Type USD Million (2018-2023)
  • Table 59. Germany New Generation Implants, by Application USD Million (2018-2023)
  • Table 60. Germany New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 61. France New Generation Implants, by Type USD Million (2018-2023)
  • Table 62. France New Generation Implants, by Application USD Million (2018-2023)
  • Table 63. France New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 64. Italy New Generation Implants, by Type USD Million (2018-2023)
  • Table 65. Italy New Generation Implants, by Application USD Million (2018-2023)
  • Table 66. Italy New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 67. United Kingdom New Generation Implants, by Type USD Million (2018-2023)
  • Table 68. United Kingdom New Generation Implants, by Application USD Million (2018-2023)
  • Table 69. United Kingdom New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 70. Netherlands New Generation Implants, by Type USD Million (2018-2023)
  • Table 71. Netherlands New Generation Implants, by Application USD Million (2018-2023)
  • Table 72. Netherlands New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 73. Rest of Europe New Generation Implants, by Type USD Million (2018-2023)
  • Table 74. Rest of Europe New Generation Implants, by Application USD Million (2018-2023)
  • Table 75. Rest of Europe New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 76. MEA New Generation Implants, by Country USD Million (2018-2023)
  • Table 77. MEA New Generation Implants, by Type USD Million (2018-2023)
  • Table 78. MEA New Generation Implants, by Application USD Million (2018-2023)
  • Table 79. MEA New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 80. Middle East New Generation Implants, by Type USD Million (2018-2023)
  • Table 81. Middle East New Generation Implants, by Application USD Million (2018-2023)
  • Table 82. Middle East New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 83. Africa New Generation Implants, by Type USD Million (2018-2023)
  • Table 84. Africa New Generation Implants, by Application USD Million (2018-2023)
  • Table 85. Africa New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 86. North America New Generation Implants, by Country USD Million (2018-2023)
  • Table 87. North America New Generation Implants, by Type USD Million (2018-2023)
  • Table 88. North America New Generation Implants, by Application USD Million (2018-2023)
  • Table 89. North America New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 90. United States New Generation Implants, by Type USD Million (2018-2023)
  • Table 91. United States New Generation Implants, by Application USD Million (2018-2023)
  • Table 92. United States New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 93. Canada New Generation Implants, by Type USD Million (2018-2023)
  • Table 94. Canada New Generation Implants, by Application USD Million (2018-2023)
  • Table 95. Canada New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 96. Mexico New Generation Implants, by Type USD Million (2018-2023)
  • Table 97. Mexico New Generation Implants, by Application USD Million (2018-2023)
  • Table 98. Mexico New Generation Implants, by Raw Material USD Million (2018-2023)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. New Generation Implants: by Type(USD Million)
  • Table 110. New Generation Implants Endosteal, , by Region USD Million (2025-2030)
  • Table 111. New Generation Implants Subperiosteal, , by Region USD Million (2025-2030)
  • Table 112. New Generation Implants Zygomatic. , by Region USD Million (2025-2030)
  • Table 113. New Generation Implants: by Application(USD Million)
  • Table 114. New Generation Implants Orthopedic Implants , by Region USD Million (2025-2030)
  • Table 115. New Generation Implants Cardiovascular Implants , by Region USD Million (2025-2030)
  • Table 116. New Generation Implants Ocular Implants , by Region USD Million (2025-2030)
  • Table 117. New Generation Implants Dental Implants , by Region USD Million (2025-2030)
  • Table 118. New Generation Implants: by Raw Material(USD Million)
  • Table 119. New Generation Implants Metals and Alloys , by Region USD Million (2025-2030)
  • Table 120. New Generation Implants Ceramics , by Region USD Million (2025-2030)
  • Table 121. New Generation Implants Polymers , by Region USD Million (2025-2030)
  • Table 122. New Generation Implants Biologicals , by Region USD Million (2025-2030)
  • Table 123. New Generation Implants Others , by Region USD Million (2025-2030)
  • Table 124. South America New Generation Implants, by Country USD Million (2025-2030)
  • Table 125. South America New Generation Implants, by Type USD Million (2025-2030)
  • Table 126. South America New Generation Implants, by Application USD Million (2025-2030)
  • Table 127. South America New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 128. Brazil New Generation Implants, by Type USD Million (2025-2030)
  • Table 129. Brazil New Generation Implants, by Application USD Million (2025-2030)
  • Table 130. Brazil New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 131. Argentina New Generation Implants, by Type USD Million (2025-2030)
  • Table 132. Argentina New Generation Implants, by Application USD Million (2025-2030)
  • Table 133. Argentina New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 134. Rest of South America New Generation Implants, by Type USD Million (2025-2030)
  • Table 135. Rest of South America New Generation Implants, by Application USD Million (2025-2030)
  • Table 136. Rest of South America New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 137. Asia Pacific New Generation Implants, by Country USD Million (2025-2030)
  • Table 138. Asia Pacific New Generation Implants, by Type USD Million (2025-2030)
  • Table 139. Asia Pacific New Generation Implants, by Application USD Million (2025-2030)
  • Table 140. Asia Pacific New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 141. China New Generation Implants, by Type USD Million (2025-2030)
  • Table 142. China New Generation Implants, by Application USD Million (2025-2030)
  • Table 143. China New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 144. Japan New Generation Implants, by Type USD Million (2025-2030)
  • Table 145. Japan New Generation Implants, by Application USD Million (2025-2030)
  • Table 146. Japan New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 147. India New Generation Implants, by Type USD Million (2025-2030)
  • Table 148. India New Generation Implants, by Application USD Million (2025-2030)
  • Table 149. India New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 150. South Korea New Generation Implants, by Type USD Million (2025-2030)
  • Table 151. South Korea New Generation Implants, by Application USD Million (2025-2030)
  • Table 152. South Korea New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 153. Taiwan New Generation Implants, by Type USD Million (2025-2030)
  • Table 154. Taiwan New Generation Implants, by Application USD Million (2025-2030)
  • Table 155. Taiwan New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 156. Australia New Generation Implants, by Type USD Million (2025-2030)
  • Table 157. Australia New Generation Implants, by Application USD Million (2025-2030)
  • Table 158. Australia New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 159. Rest of Asia-Pacific New Generation Implants, by Type USD Million (2025-2030)
  • Table 160. Rest of Asia-Pacific New Generation Implants, by Application USD Million (2025-2030)
  • Table 161. Rest of Asia-Pacific New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 162. Europe New Generation Implants, by Country USD Million (2025-2030)
  • Table 163. Europe New Generation Implants, by Type USD Million (2025-2030)
  • Table 164. Europe New Generation Implants, by Application USD Million (2025-2030)
  • Table 165. Europe New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 166. Germany New Generation Implants, by Type USD Million (2025-2030)
  • Table 167. Germany New Generation Implants, by Application USD Million (2025-2030)
  • Table 168. Germany New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 169. France New Generation Implants, by Type USD Million (2025-2030)
  • Table 170. France New Generation Implants, by Application USD Million (2025-2030)
  • Table 171. France New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 172. Italy New Generation Implants, by Type USD Million (2025-2030)
  • Table 173. Italy New Generation Implants, by Application USD Million (2025-2030)
  • Table 174. Italy New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 175. United Kingdom New Generation Implants, by Type USD Million (2025-2030)
  • Table 176. United Kingdom New Generation Implants, by Application USD Million (2025-2030)
  • Table 177. United Kingdom New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 178. Netherlands New Generation Implants, by Type USD Million (2025-2030)
  • Table 179. Netherlands New Generation Implants, by Application USD Million (2025-2030)
  • Table 180. Netherlands New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 181. Rest of Europe New Generation Implants, by Type USD Million (2025-2030)
  • Table 182. Rest of Europe New Generation Implants, by Application USD Million (2025-2030)
  • Table 183. Rest of Europe New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 184. MEA New Generation Implants, by Country USD Million (2025-2030)
  • Table 185. MEA New Generation Implants, by Type USD Million (2025-2030)
  • Table 186. MEA New Generation Implants, by Application USD Million (2025-2030)
  • Table 187. MEA New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 188. Middle East New Generation Implants, by Type USD Million (2025-2030)
  • Table 189. Middle East New Generation Implants, by Application USD Million (2025-2030)
  • Table 190. Middle East New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 191. Africa New Generation Implants, by Type USD Million (2025-2030)
  • Table 192. Africa New Generation Implants, by Application USD Million (2025-2030)
  • Table 193. Africa New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 194. North America New Generation Implants, by Country USD Million (2025-2030)
  • Table 195. North America New Generation Implants, by Type USD Million (2025-2030)
  • Table 196. North America New Generation Implants, by Application USD Million (2025-2030)
  • Table 197. North America New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 198. United States New Generation Implants, by Type USD Million (2025-2030)
  • Table 199. United States New Generation Implants, by Application USD Million (2025-2030)
  • Table 200. United States New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 201. Canada New Generation Implants, by Type USD Million (2025-2030)
  • Table 202. Canada New Generation Implants, by Application USD Million (2025-2030)
  • Table 203. Canada New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 204. Mexico New Generation Implants, by Type USD Million (2025-2030)
  • Table 205. Mexico New Generation Implants, by Application USD Million (2025-2030)
  • Table 206. Mexico New Generation Implants, by Raw Material USD Million (2025-2030)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global New Generation Implants: by Type USD Million (2018-2023)
  • Figure 5. Global New Generation Implants: by Application USD Million (2018-2023)
  • Figure 6. Global New Generation Implants: by Raw Material USD Million (2018-2023)
  • Figure 7. South America New Generation Implants Share (%), by Country
  • Figure 8. Asia Pacific New Generation Implants Share (%), by Country
  • Figure 9. Europe New Generation Implants Share (%), by Country
  • Figure 10. MEA New Generation Implants Share (%), by Country
  • Figure 11. North America New Generation Implants Share (%), by Country
  • Figure 12. Global New Generation Implants share by Players 2023 (%)
  • Figure 13. Global New Generation Implants share by Players (Top 3) 2023(%)
  • Figure 14. Global New Generation Implants share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 18. Arthrex (United States) Revenue, Net Income and Gross profit
  • Figure 19. Arthrex (United States) Revenue: by Geography 2023
  • Figure 20. Biotronik SE & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Biotronik SE & Co. KG (Germany) Revenue: by Geography 2023
  • Figure 22. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 24. C. R. BARD, INC. (United States) Revenue, Net Income and Gross profit
  • Figure 25. C. R. BARD, INC. (United States) Revenue: by Geography 2023
  • Figure 26. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Danaher Corporation (United States) Revenue: by Geography 2023
  • Figure 28. Dentsply Sirona (United States) Revenue, Net Income and Gross profit
  • Figure 29. Dentsply Sirona (United States) Revenue: by Geography 2023
  • Figure 30. Edwards Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Edwards Lifesciences Corporation (United States) Revenue: by Geography 2023
  • Figure 32. Globus Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Globus Medical Inc. (United States) Revenue: by Geography 2023
  • Figure 34. Integer Holdings Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Integer Holdings Corporation (United States) Revenue: by Geography 2023
  • Figure 36. Global New Generation Implants: by Type USD Million (2025-2030)
  • Figure 37. Global New Generation Implants: by Application USD Million (2025-2030)
  • Figure 38. Global New Generation Implants: by Raw Material USD Million (2025-2030)
  • Figure 39. South America New Generation Implants Share (%), by Country
  • Figure 40. Asia Pacific New Generation Implants Share (%), by Country
  • Figure 41. Europe New Generation Implants Share (%), by Country
  • Figure 42. MEA New Generation Implants Share (%), by Country
  • Figure 43. North America New Generation Implants Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Arthrex (United States)
  • Biotronik SE & Co. KG (Germany)
  • Boston Scientific Corporation (United States)
  • C. R. BARD, INC. (United States)
  • Danaher Corporation (United States)
  • Dentsply Sirona (United States)
  • Edwards Lifesciences Corporation (United States)
  • Globus Medical Inc. (United States)
  • Integer Holdings Corporation (United States)
Additional players considered in the study are as follows:
Integra LifeSciences Corporation (United States) , Institut Straumann AG (Switzerland) , LifeNet Health, Inc. (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 234 Pages 94 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global New Generation Implants Quantitative research analysis
Global New Generation Implants Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global New Generation Implants market are Abbott Laboratories (United States), Arthrex (United States), Biotronik SE & Co. KG (Germany), Boston Scientific Corporation (United States), C. R. BARD, INC. (United States), Danaher Corporation (United States), Dentsply Sirona (United States), Edwards Lifesciences Corporation (United States), Globus Medical Inc. (United States) and Integer Holdings Corporation (United States), to name a few.
"Increase in research and development for the discovery of new products" is seen as one of major influencing trends for New Generation Implants Market during projected period 2023-2030.
endosteal, segment in Global market to hold robust market share owing to "Growing cases of chronic diseases and the increasing geriatric population ".

Know More About Global New Generation Implants Report?

Have a Query? Click Here

Other Related Reports

Bartter Syndrome Treatment Comprehensive Study by Type (Medication, Therapy), Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Genes Types (LC12A1 Gene, KCNJ1 Gene, CLCNKB Gen...
$ 3750
Nasopharyngeal Cancer Comprehensive Study by Type (Keratinizing Squamous Cell Carcinoma, Nonkeratinizing Squamous Cell Carcinoma, Undifferentiated or Poorly Differentiated), Application (Hospitals, C...
$ 3650
Pituitary cancer Comprehensive Study by Type (Surgery, Endoscopic Transnasal Transsphenoidal Surgery, Craniotomy, Radiation Therapy, Stereotactic Radiosurgery, External beam radiation, Intensity Modu...
$ 3750
Chronic Traumatic Encephalopathy (CTE) Comprehensive Study by Type (Medical Treatment, Physical Therapy), Application (Athletes, Military Veterans, Other), End Users (Hospital & Clinic, Diagnostic Ce...
$ 3650
Progressive Multifocal Leukoencephalopathy Treatment Comprehensive Study by Type (Anti-Retroviral Therapy, Antiviral/Anti JCV, Other Symptomatic), Application (Hospital Pharmacies, Drug Stores, Retai...
$ 3750
Duodenal Ulcer Treatment Comprehensive Study by Type (True gastric ulcers, Combined gastric and duodenal ulcers., Suprapyloric and pyloric ulcers, Multiple ulcers of the stomach, Secondary gastric ul...
$ 3750